ORTHO™ Sera Anti-Fyb
- UID
- IMP/MD/2018/000042_53a59091fce187adad08b53c7bc42b4c_374868a31920928b4944207c623b8cb2
- Device class
- Class D
- Brand name
- ORTHO™ Sera Anti-P1
- Approving authority
- CDSCO
- Product information
- For in vitro diagnostic use only. For Indirect Antiglobulin Test by Column Agglutination Technology. The Anti-Fyb reagent is for the qualitative in vitro detection of human Fyb positive red blood cells by the indirect antiglobulin test
ORTHO™ Sera Anti-Fyb is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000042_53a59091fce187adad08b53c7bc42b4c_374868a31920928b4944207c623b8cb2. This device is marketed under the brand name ORTHO™ Sera Anti-P1. The license holder is M/s. Ortho Clinical Diagnostics India Private Limited ,Gala No. 20, Gr. Fl., Warehouse No.7B, BGR Logistics Park , NH-3 , Village Vahuli, Post.Padgha, Tal.-Bhiwandi, Dist -Thane ,Thane Maharashtra ,421302 ,India, and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.